CD8A and neoplasm: Patients with lower age (P = 0.048), high tumor differentiation (P = 0.001), T1/T2 staging (P < 0.001), low IL10 expression (P < 0.001), and low CD8 expression (P = 0.023) exhibited lower PD-L1 expression levels.